Table 3 Coagulation profile in various disease state and control
| Â | New Disease | Relapse | Remission | Control | Group p value | ND vs Rel | ND vs Rem | ND vs Con | Rel. Vs Rem | Rel. Vs Con | Rem vs Con |
|---|---|---|---|---|---|---|---|---|---|---|---|
Sample size (N) | 7 | 19 | 20 | 46 | Â | Â | Â | Â | Â | Â | Â |
Fibrinogen (g/l) (1.5 – 3.5) | |||||||||||
 Median |  |  |  |  |  |  |  |  |  |  |  |
 Median | 4.9 | 4.1 | 2.3 | 3.0 | 0.001* |  > 0.05 |  > 0.05 |  > 0.05 | 0.001* |  > 0.05 | 0.001* |
 IQR | 0.9 -6.2 | 2.3 – 5.5 | 1.9 – 2.6 | 2.4 – 4.0 |  |  |  |  |  |  |  |
AT (%) (80–140) | |||||||||||
 Median | 141.0 | 142.0 | 143.5 | 131.0 | 0.334 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |
 IQR | 118.0 – 148.0 | 128.0 – 152.0 | 130.5 -149.0 | 125.0 -146.0 |  |  |  |  |  |  |  |
APTT (s) (36 -50) | |||||||||||
 Median | 43.0 | 46.0 | 39.8 -50.0 | 42.0 | 0.148 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |  > 0.05 |
 IQR | 38.0 – 69.5 | 39.8 -68.3 |  | 38.0 -45.3 |  |  |  |  |  |  |  |